Given its survival benefit, surgeons must use IABP in a pre-planned way. Here by we recommend that the use of risk prediction score for patient undergoing coronary revascularization surgery is useful.
Introduction
Intraaortic balloon pump (IABP) is the most common mechanical assist device used for the treatment of low cardiac output in patients undergoing coronary artery bypass grafting (CABG). The counterpulsation theory was described by Harken in 1958 which lead to the first introduction of IntraAortic Balloon Pump (IABP) in 1968 by Kantrowiz group 1, 2 . The use of balloon pumps increased substantially from 1968 to 1995 [3] [4] [5] , and IABP use increased progressively in patients who experienced difficult weaning from cardiopulmonary bypass (CPB) 6, 7 .
IABP successfully increase coronary artery blood ûow during diastole by inûating, and decrease the workload of the heart by deûating just before systole, thus reducing afterload 8 . LV volume and LV end-diastolic pressure (EDP) have been demonstrated to decrease in patients treated (Bangladesh Heart Journal 2017; 32(2) : [94] [95] [96] [97] [98] [99] with IABP, whereas cardiac output, ejection fraction (EF), and coronary ûow may increase [9] [10] [11] .
The LV performance is one of the most important predictor of CABG outcome. In most cases the patient with poor Left ventricular (LV) function is receiving an IABP counterpulsation support. Acute volume load applied during contraction or relaxation phase in heart muscle, increases or decreases the ejection phase duration, respectively. Moreover, altered loading conditions may result in dyssynchronous relaxation of the LV [12] [13] .
Myocardial relaxation is known to be sensitive to afterload and to LV-dyssynchrony in patients with dilated cardiomyopathy 14 . LV mechanical dyssynchrony in these patients decreased due to reduction in wall stress induced by interventions such as vasodilators, cardiomyoplasty, or LV ventricular reduction surgery. Hence IABP in patients with low EF may considerably inûuence cardiac performance by acute afterload changes and concomitant changes in LV mechanical dyssynchrony.
Unfortunately patients with preserved LV function may require IABP support for a number of factors e.g. advanced age, female sex, left main stenosis, redo operation, recent myocardial infarction and difficult to wean from cardio pulmonary bypass due to post-surgical myocardial dysfunction. However, overall mortality in patients receiving intraoperative or postoperative IABP remains high, ranging from 27% to 52% 15 . The survivors, irrespective of their preoperative LV performance are shown altogether to have a better outcome in postoperative periods in most of the studies.
Some prospective randomized and observational studies suggest that preoperative IABP insertion in high-risk patients undergoing CABG decreases mortality and morbidity, and shortens postoperative hospital length of stay 16, 17 . But insertion practices vary, with the Benchmark Registry and Society of Thoracic Surgeons database and hence the role of the preoperative prophylactic IABP is subject to debate 18 .
Thus the conflict persists in issue concerning the timing of IABP insertion and identification of appropriate candidacy for IABP. Although the outcome of IABP in patients with poor LV function is documented well, no comprehensive study showed the outcome for preserved LV function group. To the best of our knowledge, there has been no study done so far in Bangladesh regarding the IABP outcome in CABG patients. Therefore it seems logical to investigate. Accordingly, we sought to identify the outcome of patients receiving IABP support by concentrating upon LV performance.
Materials &Methods
This study was a hospital-based prospective observational study andwas conducted in the Department of Cardiac Surgery, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh from July 2013 to June 2014 (1 year). Data collected from all patients who underwent elective or emergency Coronary artery bypass grafting (CABG) surgeryrequiring IABP support perioperatively. Patients were excluded from the study who has renal dysfunction (Creatinine>2.0 mg/dl), acute or chronic pulmonary disease,associated valvular heart disease, or associated congenital cardiac anomaly; requiring coronary end-arterectomy and/or Re-do coronary artery bypass grafting. Sample size was calculated using the mean difference of EDP (End diastolic pressure) to evaluate LV performance in patients with IABP with low ejection fraction, reported by Schreuder et al., 2005 19 .
A prognostic risk stratiûcation model (Table-1) to predict the need for IABP insertion in patients undergoing CABG proposed by Antonio Miceliet al 20 in 2010 was used to evaluate its usefulness. All the patients are prospectively allocated into two groups. Group A: Constitute patients with preserved LV, Group B: Constitute patients with poor LV function.
A 5-MHz phased-array transesophageal transducer (GE: Healthcare Vivid-7 pro) was used for Transesophageal Echocadiography to measure left ventricle ejection fraction (EF) both prebypass and postbypass states. A trans-thoracic echocardiography was done on second post-operative day, during discharge, at all the followup of the patient with GE: Vivid 7-pro. Trans-thoracic echocardiography was done by Non-invasive Echocardiography consultants of NHFH&RI blinded towards the study. Biochemical markers; Troponin-I and NT-proBNP analysis were done with Siemens Stratus CS Acute Care Diagnostic System; Flurometric analyser. A single data of each was documented and the highest value of these results was taken if repeated test were done. All the biochemical tests were done at the Department of Biochemistry at NHFH&RI.
Keeping compliance with Helsinki Declaration for Medical
Research Involving Human Subjects 1964, all patients were informed verbally about the study design, the purpose of the study, and right of the participants to withdraw themselves from the project, at any time for any reason.Written consent was obtained from each subject in a pre-formed consent paper which was written in easily understandable local language.The study was approved by Ethical review committee of NHFH&RI and due clearance was obtained.The study was commenced following acceptance of the protocol by BCPS. Data were processed using The Effects of Perioperative Intra-aortic Balloon Counter Pulsationsoftware SPSS (Statistical Package for Social Sciences) version 16.0 and for all analytical tests, the level of significance was set at 0.05 and p < 0.05 was considered significant.
Results
The present study performed in NHFH&RI, Dhaka, included 60 patients divided into 2 groups. The age ranged from 35 years to 67 years, but mean ages of the Group A and Group B was 53.21±6.66 and 52.97±7.77 respectively. Although a male preponderance was observed in both groups, the difference between the groups with respect to sex was not evident (Fig-1) . Both the groups were identical in respect of height, weight, BMI and BSA. Distribution of overweight and obese patients was almost equal in both groups. Figure 1 shows the sex distribution of the patients. Out of 60 patients, male was predominant 60.7% in Group A, 71.9% in Group B. The two groups' difference was not statistically significant by Fisher's Exact Test (p=0.261).
and Smoking habit etc is delineated in Table-2 . Other clinical characteristics which has potential influence in the outcome of coronary artery bypass surgery were also evaluted.
The extent of coronary artery disease was similar in both the groups and most of the patients were having triple vessel disease. A large number of patients in both the groups had Left main coronary artery disease 57.1% and 40.6% respectively. In regards to Echocardiography findings; there was no significant difference in both groups in terms of LVEF and left ventricular end diastolic diameter.However, Group A and Group B showed left ventricular end systolic diameter 39.25±3.329 vs 45.53±5.061 which was statistically significant (p=0.013). Regional wall motion abnormality was also found statistically significant in between Group A and Group B; these are expected in patients with low ejection fraction.
Operative urgency is an important predictor of coronary revascularization surgery. In our study we found emergency surgery was 25% in Group A and 18.8% in Group B; Urgent surgery was 39.3% and 40.6% respectively and rest were elective cases. The distribution was statistically not significant in all cases. All patients were assessed by using Euroscore-II and Logistic Euroscore, no statistical difference was found.
Intra-aortic balloon pump is used in peri-operative period as per hospital protocol and by using IABP-score. We evaluated the insertion of IABP in pre, per and post-operative periods. 46.4% patients received IABP in Group A in preoprative period than that of 50% of the patients of Group B. In all perioperative period the use of IABP in both the groups were statistically non significant.
The post-operative out come between the groups was equivocal (Table-3 ). Other post operative complication The risk factors for ischemic heart disease like Diabetes was sub-classed in to Non diabetic, Diet control diabetes, Oral pills and insulin controlled diabetes. The difference between two groups was not statistically significant. Other cardiac risk factors included Hypertension, Hyperlipidemia including renal failure and arrythmia were equally high in both the groups (p=0.673). Although the rate of morbidity was higher in both the groups the status of the patients at 30 days was found better.
Discussion
The present study was designed to compare the LV function for highly selective group of patients undergoing coronary revascularization surgery to find the answer of the research question "Preserved LV function shows better outcome with Intra-aortic balloon counter pulsation therapy". We matched the pre-operative clinical characteristics of both the groups apart from Echocardiographic LV function parameters. Clinical characteristics which has potential influence in the outcome of coronary artery bypass surgery were evaluted 8 . Apart from this all other perioperative outcome variables were non-significant between the groups when compared to other published reports. Overall mortality in patients receiving intraoperative or postoperative IABP reported Baskettet al in 2002 was higher than our result 15 . About 93% patients of Group A were alive at 30 days in comparison with 93.8% of Group B (Table-3 ).
This is a single centre non-randomized study. A multivariate regression analysis was not done, which we believe could be useful to verify the profound cause-effect-outcome. We applied blinding (The Echocardigraphers were blinded towards the grouping) but the sample sizewas small due to short duration (1year)and non-funded post-graduation study oriented research.
Conclusion
This study shows that, use of IABP in preserved LV function patients does not show any survival benefit at 30 days and no difference in outcome in terms of LVEF, LVIDd, and LVIDs when measured with TVI and CFM.The results of this study and discussion thereof prompt us to recommend that there is no significant advantage in terms of LV function in patients with coronary revascularization requiring IABP.
Intra-aortic balloon pump is a life-saving assist device and its use should be considered in myocardial revascularization surgery, when indicated. A judicious use of IABP is life saving and need to preserve its use for the appropriate cases. Given its survival benefit, surgeons must use IABP in a pre-planned way. Here by the recommendation is the use of risk prediction scorefor patient undergoing coronary revascularization surgery is useful.
